Royal Society of Chemistry
|Agreement labeling||Read & Publish License Agreement|
|Has the agreement been fully disclosed and published?||Yes|
|Agreement period||01/01/2022 – 12/31/2024|
|Consortia / Institution||HEAL-Link (Hellenic Academic Libraries Link)|
Approximate range of annual corresponding author publications
|Comments on size/article output||60 is HEAL-Link’s article output in 2022|
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
|Comments on cost development||A cost increase from previous read and publish spending level due to the inclusion of publishing in selective gold OA journals as an add-on option to the agreement|
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Subscriptions partly converted to OA publishing fees|
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?
|Capped agreement. Article entitlements per contract year have been set. If the article entitlements are exceeded in any year, an author-pays route will follow with a 15% APC discount.|
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?||Fully OA titles are included selectively|
|OA LICENSE||CC-BY variations allowed|
||All article types|
What is the approximate share of access related costs of the overall agreement?
|More than 50%|
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||Yes|
|OVERALL ASSESSMENT AND COMMENTS||Satisfactory|
|Request contact to the licensee||contact [at] esac-initiative [dot] org|